A
$ Value
$0
Shares
20,000
Price
$0
Filed
Jun 26
Insider
Name
Stein Jeffrey
Title
—
CIK
0001478831
Roles
Director
Transaction Details
Transaction Date
2025-06-24
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
20,000
Footnotes
100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date.
Filing Info
Stein Jeffrey's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-07 | CDTX | D | $1.3M |
| 2026-01-07 | CDTX | D | $527K |
| 2026-01-07 | CDTX | D | $15.0M |
| 2026-01-07 | CDTX | D | — |
| 2026-01-07 | CDTX | D | — |
| 2026-01-07 | CDTX | D | — |
| 2026-01-07 | CDTX | D | — |
| 2026-01-07 | CDTX | D | — |
| 2026-01-07 | CDTX | D | — |
| 2026-01-07 | CDTX | D | — |
Other Insiders at IDYA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Beaupre Darrin
Chief Medical Officer
|
— | — | 2026-01-30 |
|
Hata Yujiro S
President and CEO
|
— | — | 2026-01-30 |
|
Snyder Douglas B.
SVP, General Counsel
|
— | — | 2026-01-30 |
|
WHITE MICHAEL ANTHONY
Chief Scientific Officer
|
— | — | 2026-01-30 |
|
Ruiz Briseno Andres
See Remarks
|
— | — | 2026-01-30 |
|
DORMAN STUART
Chief Commercial Officer
|
— | — | 2026-01-30 |
|
Bleharski Joshua
Chief Financial Officer
|
— | — | 2026-01-30 |